The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage
Abstract
Homocysteine (HC) is a neurotoxic amino acid that accumulates in several neurological disorders including Alzheimer's disease (AD). We examined the consequences of treatment of cultured murine cortical neurons with HC. Homocysteine‐induced increases in cytosolic calcium, reactive oxygen species, phospho‐tau immunoreactivity and externalized phosphatidyl serine (indicative of apoptosis). Homocysteine‐induced calcium influx through NMDA channel activation, which stimulated glutamate excitotoxicity, as evidenced by treatment with antagonists of the NMDA channel and metabotropic glutamate receptors, respectively. The NMDA channel antagonist MK‐801 reduced tau phosphorylation but not apoptosis after HC treatment, suggesting that HC‐mediated apoptosis was not due to calcium influx. Apoptosis after HC treatment was reduced by co‐treatment with 3‐aminobenazmidine (3ab), an inhibitor of poly‐ADP‐ribosome polymerase (PARP), consistent with previous reports that ATP depletion by PARP‐mediated repair of DNA strand breakage mediated HC‐induced apoptosis. Treatment with 3ab did not reduce tau phosphorylation, however, therefore hyperphosphorylation of tau may not contribute to HC‐induced apoptosis under these conditions. Inhibition of mitogen‐activated protein kinase by co‐treatment with the kinase inhibitor PD98059 inhibited tau phosphorylation but not apoptosis after HC treatment. HC accumulation reduces cellular levels of S‐adenosyl methionine (SAM); co‐treatment with SAM reduced apoptosis, suggesting that inhibition of critical methylation reactions may mediate HC‐induced apoptosis. These findings indicate that HC compromises neuronal homeostasis by multiple, divergent routes. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408
Glutamate receptors in the mammalian central nervous system
Ozawa, S., Kamiya, H., & Tsuzuki, K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00085-3 · Cited by 1,122
Pang, L., Sawada, T., Decker, S. J., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13585 · Cited by 896
Neurotoxicity associated with dual actions of homocysteine at the N -methyl- d -aspartate receptor
Lipton, S. A., Kim, W.-K., Choi, Y.-B., Kumar, S., D’Emilia, D. M., Rayudu, P. V., Arnelle, D. R., & Stamler, J. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5923 · Cited by 847
Kruman, I. I., Culmsee, C., Chan, S. L., Kruman, Y., Guo, Z., Penix, L., & Mattson, M. P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06920.2000 · Cited by 784
Kinetic and catalytic mechanism of HhaI methyltransferase.
Wu, J. C., & Santi, D. V. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61263-3 · Cited by 420
Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35
Forloni, G., Chiesa, R., Smiroldo, S., Verga, L., Salmona, M., Tagliavini, F., & Angeretti, N. (1993) · NeuroReport · doi:10.1097/00001756-199305000-00015 · Cited by 341
Compagnone, N. A., & Mellon, S. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4678 · Cited by 327
Ueda, K., Shinohara, S., Yagami, T., Asakura, K., & Kawasaki, K. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010265.x · Cited by 319
Metabolism of Homocysteine Thiolactone in Human Cell Cultures
Jakubowski, H. (1997) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67504-6 · Cited by 299
Mattson, M. P. (1990) · Neuron · doi:10.1016/0896-6273(90)90447-n · Cited by 288
Homocysteine potentiates β‐amyloid neurotoxicity: role of oxidative stress
Ho, P. I., Collins, S. C., Dhitavat, S., Ortiz, D., Ashline, D., Rogers, E., & Shea, T. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00384.x · Cited by 269
Self-citationWhite, A. R., Huang, X., Jobling, M. F., Barrow, C. J., Beyreuther, K., Masters, C. L., Bush, A. I., & Cappai, R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00178.x · Cited by 260
Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker
Lehmann, M., Gottfries, C. G., & Regland, B. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017092 · Cited by 245
Joosten, E., Lesaffre, E., Riezler, R., Ghekiere, V., Dereymaeker, L., Pelemans, W., & Dejaeger, E. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.2.m76 · Cited by 187
Ekinci, F. J., Malik, K. U., & Shea, T. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30322 · Cited by 163
Self-citationKim, W.-K., & Pae, Y.-S. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13011-1 · Cited by 154
Sato, M., Suzuki, K., & Nakanishi, S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-11-03797.2001 · Cited by 128
Neurodegeneration mediated by glutamate and β-amyloid peptide: a comparison and possible interaction
Gray, C. W., & Patel, A. J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00669-h · Cited by 117
Increased surface phosphatidylserine is an early marker of neuronal apoptosis
Rimon, G., Bazenet, C. E., Philpott, K. L., & Rubin, L. L. (1997) · Journal of Neuroscience Research · Cited by 115
Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis
Hölscher, C. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0193 · Cited by 112
Silei, V., Fabrizi, C., Venturini, G., Salmona, M., Bugiani, O., Tagliavini, F., & Lauro, G. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01272-4 · Cited by 112
Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease
LEVITT, A. J., & Karlinsky, H. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03270.x · Cited by 86
Abnormal amino acid metabolism in patients with early stage Alzheimer dementia
Fekkes, D., van der Cammen, T. J. M., van Loon, C. P. M., Verschoor, C. J., van Harskamp, F., de Koning, I., Schudel, W. J., & Pepplinkhuizen, L. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050058 · Cited by 84
Age-Related Changes in Cobalamin (Vitamin B12) Handling
Nilsson‐Ehle, H. (1998) · Drugs & Aging · doi:10.2165/00002512-199812040-00003 · Cited by 79
Vitamins B12, B6 and folate as determinants of homocysteine concentration in the healthy population
Pietrzik, K. F., & Brönstrup, A. (1998) · European Journal of Pediatrics · doi:10.1007/pl00014298 · Cited by 76
Kreis, W., & Goodenow, M. M. (1978) · PubMed · Cited by 75
Parsons, R. B., Waring, R. H., Ramsden, D. B., & Williams, A. C. (1998) · PubMed · Cited by 73
Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population
Nilsson, K. H., Gustafson, L., Fäldt, R., Andersson, A. D. R., & Hultberg, B. L. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb01111.x · Cited by 71
Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease
Gottfries, C. G., Lehmann, W., & Regland, B. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050094 · Cited by 63
Low B12 levels related to high activity of platelet MAO in patients with dementia disorders
Regland, B., Gottfries, C. G., Oreland, L., & Svennerholm, L. T. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06366.x · Cited by 60
Jensen, J. B., Schousboe, A., & Pickering, D. S. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00130-7 · Cited by 49
Familial Alzheimer's Disease and Vitamin B12 Deficiency
McCaddon, A., Kelly, C. L., & Tibblin, G. (1994) · Age and Ageing · doi:10.1093/ageing/23.4.334 · Cited by 48
Fiskerstrand, T., Ueland, P. M., & Refsum, H. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36936-8 · Cited by 47
Hyperosmotic stress‐induced apoptosis and tau phosphorylation in human neuroblastoma cells
Stoothoff, W. H., & Johnson, G. V. W. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1187 · Cited by 44
Shea, T. B., Prabhakar, S., & Ekinci, F. J. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970915)49:6<759::aid-jnr10>3.0.co;2-n · Cited by 40
Self-citationHou, J. W., & Wang, T.-R. (1998) · European Journal of Pediatrics · doi:10.1007/s004310050782 · Cited by 33
Homocysteine and α -Lipoic Acid Regulate p44/42 MAP Kinase Phosphorylation in NIH/3T3 Cells
Shi, S. S., Day, R. M., Halpner, A. D., Blumberg, J. B., & Suzuki, Y. (1999) · Antioxidants and Redox Signaling · doi:10.1089/ars.1999.1.1-123 · Cited by 20
Lucock, M. D., Daskalakis, I. G., Wild, J., Anderson, A. S., Schorah, C. J., Lean, M. E. J., & Levene, M. I. (1996) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1996.0074 · Cited by 19
ß-Amyloid-Induced Tau Phosphorylation does not Correlate with Degeneration in Cultured Neurons
Ekinci, F. J., & Shea, T. B. (2000) · Journal of Alzheimer s Disease · doi:10.3233/jad-2000-2102 · Cited by 15
Self-citationFortification of Grain Productions with Folate: Should Britain Follow the American Example?
Wynn, M., & Wynn, A. (1998) · Nutrition and Health · doi:10.1177/026010609801200301 · Cited by 8
Cited by
Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders
Mattson, M. P., & Shea, T. B. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00032-8 · Cited by 847
Self-citationObeid, R., & Herrmann, W. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.088 · Cited by 490
Homocysteine and Alzheimer's disease
Morris, M. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00438-1 · Cited by 332
Homocysteine and Alzheimer's disease
LEBOEUF, R. (2003) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(03)00032-4 · Cited by 321
Physiological and pathological phosphorylation of tau by Cdk5
Kimura, T., Ishiguro, K., & Hisanaga, S.-I. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00065 · Cited by 297
Metadata
- Authors
- Ho, P. I., Ortiz, D., Rogers, E., & Shea, T. B.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2002-11-07
- Volume
- 70
- Issue
- 5
- Pages
- 694-702
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2085527691
- Cited by
- 381
- References
- 42
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.